Frequency Therapeutics Closes $62MM Series C Financing


Congratulations to Frequency Therapeutics!

They have announced the close of their $62mm Series C financing to expand research of their innovative drug candidate for hearing restoration and its potential for other degenerative diseases using their first-in-class Progenitor Cell Activation platform.

https://www.linkedin.com/feed/update/urn:li:activity:6559391537099264001

Featured Posts